Search Count: 918
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: A1CM5, SO4 |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: DMS, A1CM6 |
 |
Organism: human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: SO4, A1CNI, GOL |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: A1CNJ, SO4 |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: A1CNK |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: A1CNO |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: A1CNY, DMS |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: SO4, A1CNZ |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: A1COE, PEG, GOL |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: SO4, YUJ |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: YUA, SO4 |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: YUP, SO4 |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: SO4, YUD |
 |
Crystal Structure Of Sars-Cov-2 Mpro S10A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S10C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: DMS, EDO, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115M In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S147A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |